Clinical Research

The clinical research team focuses on phase I/II complex clinical research and strives to evolve with industry trends by adapting to innovative approaches to early drug development, while maintaining full compliance with regulations. Pharmaron’s 96-bed, built-for-purpose facility has had three routine FDA inspections.

We have therapeutic area expertise in infectious disease, CNS, dermatology, metabolism and respiratory disease. With the successful completion of over 200 early phase studies across all therapeutic areas, Pharmaron is a trusted partner for pharmaceutical and biotech sponsors.

Integrated FIH Thorough QT/Early Phase QT Human Abuse Liability Single-site Phase II Patient Recruitment Extramural Research Program Japanese Bridging Studies Clinical Analysis Test Lab (CATLab) Bioanalysis Drug Disposition Studies Immunotoxicity and Immunogenicity for Biologics Volunteer

Learn About Our Services